| Uncovering the mechanisms of Acinetobacter baumannii virulence CM Harding, SW Hennon, MF Feldman Nature Reviews Microbiology 16 (2), 91-102, 2018 | 900 | 2018 |
| Acinetobacter baumannii strain M2 produces type IV pili which play a role in natural transformation and twitching motility but not surface-associated motility CM Harding, EN Tracy, MD Carruthers, PN Rather, LA Actis, ... MBio 4 (4), 10.1128/mbio. 00360-13, 2013 | 192 | 2013 |
| A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae MF Feldman, AE Mayer Bridwell, NE Scott, E Vinogradov, SR McKee, ... Proceedings of the National Academy of Sciences 116 (37), 18655-18663, 2019 | 152 | 2019 |
| Pathogenic Acinetobacter: from the cell surface to infinity and beyond BS Weber, CM Harding, MF Feldman Journal of bacteriology 198 (6), 880-887, 2016 | 148 | 2016 |
| The secrets of Acinetobacter secretion BS Weber, RL Kinsella, CM Harding, MF Feldman Trends in microbiology 25 (7), 532-545, 2017 | 103 | 2017 |
| Acinetobacter strains carry two functional oligosaccharyltransferases, one devoted exclusively to type IV pilin, and the other one dedicated to O‐glycosylation of … CM Harding, MA Nasr, RL Kinsella, NE Scott, LJ Foster, BS Weber, ... Molecular microbiology 96 (5), 1023-1041, 2015 | 99 | 2015 |
| Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple … CM Harding, RL Kinsella, LD Palmer, EP Skaar, MF Feldman PLoS pathogens 12 (1), e1005391, 2016 | 90 | 2016 |
| Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli CM Harding, MF Feldman Glycobiology 29 (7), 519-529, 2019 | 84 | 2019 |
| A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host CM Harding, MA Nasr, NE Scott, G Goyette-Desjardins, H Nothaft, ... Nature communications 10 (1), 891, 2019 | 82 | 2019 |
| Structural diversity in the type IV pili of multidrug-resistant Acinetobacter KH Piepenbrink, E Lillehoj, CM Harding, JW Labonte, X Zuo, CA Rapp, ... Journal of Biological Chemistry 291 (44), 22924-22935, 2016 | 81 | 2016 |
| Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems CM Harding, MR Pulido, G Di Venanzio, RL Kinsella, AI Webb, NE Scott, ... Journal of biological chemistry 292 (22), 9075-9087, 2017 | 80 | 2017 |
| KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst D Sun, SA Crowell, CM Harding, PM De Silva, A Harrison, DM Fernando, ... Life sciences 148, 31-40, 2016 | 79 | 2016 |
| Draft genome sequence of the clinical isolate Acinetobacter nosocomialis strain M2 MD Carruthers, CM Harding, BD Baker, RA Bonomo, KM Hujer, ... Genome announcements 1 (6), 10.1128/genomea. 00906-13, 2013 | 42 | 2013 |
| Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2: O1 strains of Klebsiella pneumoniae PL Wantuch, CJ Knoot, LS Robinson, E Vinogradov, NE Scott, ... PLoS pathogens 19 (5), e1011367, 2023 | 19 | 2023 |
| Characteristics of invasive Acinetobacter species isolates recovered in a pediatric academic center AL Jain, CM Harding, K Assani, CL Shrestha, M Haga, A Leber, ... BMC infectious diseases 16, 1-9, 2016 | 17 | 2016 |
| Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine JA Duke, AV Paschall, LS Robinson, CJ Knoot, E Vinogradov, NE Scott, ... ACS infectious diseases 7 (11), 3111-3123, 2021 | 16 | 2021 |
| Distinct amino acid residues confer one of three UDP-sugar substrate specificities in Acinetobacter baumannii PglC phosphoglycosyltransferases CM Harding, MF Haurat, E Vinogradov, MF Feldman Glycobiology 28 (7), 522-533, 2018 | 16 | 2018 |
| A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS CJ Knoot, LS Robinson, CM Harding Glycobiology 31 (9), 1192-1203, 2021 | 13 | 2021 |
| Discovery and characterization of a new class of O-linking oligosaccharyltransferases from the Moraxellaceae family CJ Knoot, PL Wantuch, LS Robinson, DA Rosen, NE Scott, CM Harding Glycobiology 33 (1), 57-74, 2023 | 10 | 2023 |
| Heptavalent O-Antigen Bioconjugate Vaccine Exhibiting Differential Functional Antibody Responses Against Diverse Klebsiella pneumoniae Isolates PL Wantuch, CJ Knoot, LS Robinson, E Vinogradov, NE Scott, ... The Journal of Infectious Diseases, jiae097, 2024 | 5 | 2024 |
Nichollas E ScottUniversity of Melbourne在 unimelb.edu.au 的电子邮件经过验证
